Shandong Xinhua Pharmaceutical Co (SZSE:000756) Net Income From Continuing Operations : ¥457 Mil (TTM As of Mar. 2025)

View and export this data going back to 1997. Start your Free Trial

What is Shandong Xinhua Pharmaceutical Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Shandong Xinhua Pharmaceutical Co's net income from continuing operations for the three months ended in Mar. 2025 was ¥116 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was ¥457 Mil.

Shandong Xinhua Pharmaceutical Co Net Income From Continuing Operations Historical Data

The historical data trend for Shandong Xinhua Pharmaceutical Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Xinhua Pharmaceutical Co Net Income From Continuing Operations Chart

Shandong Xinhua Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income From Continuing Operations

Get a 7-Day Free Trial

347.11

362.07

426.11

506.11

486.72

Shandong Xinhua Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Income From Continuing Operations	Get a 7-Day Free Trial															145.26	127.50	82.68	131.27	115.64

Shandong Xinhua Pharmaceutical Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥457 Mil.

Shandong Xinhua Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Xinhua Pharmaceutical Co Ltd (SZSE:000756) » Definitions » Net Income From Continuing Operations

Traded in Other Exchanges

00719:Hong Kong

Address

No. 1 Lutai Avenue, Hi-tech Industry Development Zone, Zibo, Shandong, CHN, 255086

Website

http://www.xhzy.com

Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates various segments namely Chemical raw materials, Preparations, Pharmaceutical intermediates and other products. The company is mainly engaged in the business of development, manufacture and sale of bulk pharmaceuticals, preparations and chemical products.

Executives

Wang Xiao Long	Executives
Du De Qing	Executives
Zhang Dai Ming	Director
Cao Zhang Qiu	Secretary Dong
Xu Lie	Director
Wei Zhang Sheng	Executives
He Tong Qing	Directors, executives
Zheng Zhong Hui	Executives
Xu Wen Hui	Executives
Guo Qin	Director
Dou Xue Jie	Executives
Sun Ming Gao	Director
Fu Heng Qian	Executives
Liu Qiang	Supervisors
Gao Qing Gang	Supervisors

Shandong Xinhua Pharmaceutical Co Headlines

No Headlines